Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon challenge in adults with type 2 diabetes mellitus
NL-OMON33022Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label trial of glucagon in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Hepatic glucose production, Plasma glucagon concentration and 5 more. Started Oct 2009; status: active, not recruiting.
02
Drugs
glucagon
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON33022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33022.